07/03/2025
2:30 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
2:31 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
2:31 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
12:01 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2025
12:05 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2025
12:07 PM | Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/27/2025
4:20 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2025
9:43 AM | FMR LLC (Filed by)
Viking Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/24/2025
3:37 PM | Viking Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2025
4:25 PM | Viking Therapeutics (Filer)
| Form DEFR14A | |
04/23/2025
4:26 PM | Viking Therapeutics (Filer)
| Form DEFA14A | |
Get the Latest News and Ratings for VKTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Viking Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/23/2025
3:01 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2025
9:00 AM | BlackRock, Inc. (Filed by)
Viking Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/14/2025
6:26 PM | FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2025
6:05 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
| Form 4/A | |
04/08/2025
4:23 PM | Viking Therapeutics (Filer)
| Form DEFA14A | |
04/08/2025
4:25 PM | Viking Therapeutics (Filer)
| Form ARS | |
04/02/2025
5:29 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
6:05 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
3:32 PM | Viking Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/06/2025
7:15 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:16 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:11 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:12 PM | FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:13 PM | Rowland Charles A Jr (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:13 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:14 PM | MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:14 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:32 PM | Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025
4:25 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025
4:16 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
5:22 PM | MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
5:13 PM | MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024
12:54 PM | VANGUARD GROUP INC (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G/A | |
11/04/2024
5:31 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
8:48 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
3:37 PM | Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
6:27 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
6:28 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
3:10 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
4:00 PM | Viking Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom (Ad) Cold War Discovery Could Unlock $100 Trillion in Wealth
Jeff recently traveled to an American ghost town to investigate this crazy Cold War story…
Because it could hold the key to the entire $100 trillion AI boom.
It involves an American ghost town with just 30 people…
And a new twist to the AI boom that could make a lot of people rich. Click here to see the details on what could be the biggest tech story of this decade. |
10/23/2024
3:09 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2024
11:26 AM | STATE STREET CORP (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G/A | |
09/20/2024
8:20 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
8:21 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
3:29 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024
6:23 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
6:23 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
7:11 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
7:13 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
7:00 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
6:47 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024
7:03 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:38 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024
3:05 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
3:05 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
3:05 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
4:55 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
4:56 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
4:58 PM | Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024
4:00 PM | Viking Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024
3:10 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
